Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 2XB45 | — |
the patient didn't receive the full dose; since it leaked; This non-serious case was reported by a consumer via call center representative and described the occurrence of accidental underdose in a 72-year-old male patient who received Herpes zoster (Shingrix) (batch number NY2AT, expiry date 26-APR-2027) and (batch number 2XB45, expiry date 26-APR-2027) for prophylaxis. On 15-SEP-2025, the patient received Shingrix (left arm). On 15-SEP-2025, an unknown time after receiving Shingrix, the patient experienced accidental underdose (Verbatim: the patient didn't receive the full dose) and product leakage (Verbatim: since it leaked). The outcome of the accidental underdose and product leakage were not applicable. Additional Information: GSK Receipt Date: 15-SEP-2025 and 16-SEP-2025 According to reporter, the patient did not receive the full dose, since it leaked. The reporter had a patient that was administered the Shingrix vaccine, and they pulled back unexpectedly, the reporter was not sure how many dose the patient got. According to reporter, the patient did not receive the full dose, since it leaked. No further details were provided.